Navigation Links
TurboVap II Concentration Workstation

ProductsTurboVap II Concentration Workstation
Company Caliper Life Sciences
Item TurboVap II Concentration Workstation
Features Inquire
Description The TurboVap Concentration Workstations from Caliper provide an automated alternative to Kuderna-Danish, Rotary, Vacuum-Style and Nitrogen Blow-Down Evaporators. For over ten years TurboVap concentration technology has received enormous acclaim with over 4,000 units in use around the world today.

Utilizing a proprietary gas-vortexing action, its fast, unattended operation doubles sample throughput, frees up resources, and improvises quality control.

TurboVaps are in routine use in thousands of environmental, food testing, pharmaceutical, NIDA, forensic and chemical laboratories worldwide. The Turbo family of products provides evaporation solutions for multiple formats, from small and large volume tubes to 96 well microplates.
TurboVap II

The TurboVap II is designed for larger volumes and works with glassware in either 50mL or 200mL sizes, and it can also be adapted to work with Dionex ASE 40mL tubes. The unit can evaporate/concentrate up to six samples simultaneously.

Info Caliper Life Sciences
Customer Service: (877) LabChip
Web site: http://www.caliperls.com/

Related medicine products :

1. TurboVap LV Concentration Workstation
2. TurboVap 96 Concentration Workstation
3. TurboVap 500 Concentration Workstation
4. Biomek 2000 Laboratory Automation Workstation
5. Biomek FX Laboratory Automation Workstation
6. Finnigan ProteomeX™ Workstation
7. Byrd Workstation Femoral Intravascular Retrieval Set
8. Zyoptix Diagnostic Workstation
9. EpochXP Neurological Workstation
10. The P45 Ultrasonic Workstation
11. BEETHOVEN II Workstation Laboratory Information System
The HYRYS™ 2 densitometer is reflective of Sebia's expertise in the development and design of imaging systems and densitometers utilized in the electrophoresis field.
Hydragel K20 is Sebia's quality line of manual agarose gel electrophoresis products. Samples are applied utilizing the same patented applicator combs that is used for sample application on the HYDRAS
Eliminating the need for any manual pipetting, the HydraPLUS delivers precise micro-volumes of sample directly from primary tubes to four HYDRASYS sample applicators contained in a built-in humidity
Handheld Digital Retinal Camera
Medicine Products:
(Date:9/5/2008)...G, Pa., Sept. 5 /PRNewswire-USNewswire/ -- Childre...r access to comprehensive,services to protect thei...n,in grants that were announced today by the Depar...vices for children and families, the department,be...ren,s Services Planning,initiative, ICSP, in 2004....
(Date:9/5/2008)..., Md., Sept. 5 /PRNewswire-USNewswire/ -- The Heal...day announced $39 million in grants to,increase an...centers., "These grants continue President Bush,s...whose services now reach more economically,vulnera...r before," HRSA,Administrator Elizabeth M. Duke sa...
(Date:9/5/2008)...ontrolled, but you need to know what triggers them...thDay News) -- If you are one of the 36 million Am...is nowhere in the United States that is free from ... shows. , Allergies don,t only happen in the sp...ell. In the fall, the most challenging cities to l...
(Date:9/5/2008)...N, Sept. 5 /PRNewswire-USNewswire/ -- Speaker Nanc...upport of the aims of the "Stand,Up to Cancer" tel...re is not a person in our country who has not seen...s 565,000 Americans annually, and each,year there ... must work,together to make eradicating the scourg...
Breaking Medicine News(10 mins):Health News:Pennsylvania Counties Receive Grants to Improve Services for Children 2Health News:HRSA Announces $39 Million in Grants to Expand, Improve Health Center Services 2Health News:No Place Safe From Allergies 2
... given us adequate reasons to make fish a part of ...popular component in fish has always hogged the sp...es conducted by Dutch researchers suggest that Ome...nst age-connected cognitive-decline. During the s...
...ement could make the aggrieved die from a broken h...hat sections in the brain in charge of memory, lea...people who are grieving. They say that important r...a negative loop which could cause heart rhythms to...
...responds to injury has found vulnerabilities simil...ied at least one significant difference. In an a...r the first time that parts of the developing brai...amate, a nervous system messenger compound. Glutam...
...e National Institute of Mental Health and Neuro Sc...strong plea for all out nationwide efforts to dete...have suggested that doctors working at primary hea...ls be educated to identify Parkinsonism and refer ...
Other Medicine News:Health News:Different Approach Needed to Protect Brains of Premature Babies 2Health News:Different Approach Needed to Protect Brains of Premature Babies 3Health News:Make Treatment of Parkinsons More Affordable, Doctors Plead 2Health News:Make Treatment of Parkinsons More Affordable, Doctors Plead 3
(Date:9/3/2008)...NAA says: Wrong Question Asked. Wrong Children Stu.... 3 /PRNewswire-USNewswire/ -- A Centers for Disea...ay claims there is no link,between the MMR vaccine...,says this study does nothing to dispel the growin...and raises several questions concerning design,and...
(Date:9/3/2008)... - Long term follow up results from chronically in...xceed positive data obtained earlier in 2008, - ...cant and long-term antiviral effect of ther... way and strongly support move into a second gener...nt IC31(R) acting through TLR ...
(Date:9/3/2008)... GAITHERSBURG, Md., Sept. 3 /- Panace...ce of U.S. Patent Number 7,413,737 covering,antibo...roxylase (HAAH), a,proprietary human cancer biomar...developed in collaboration with the Massachusetts ...usive, worldwide rights to this patent,for develop...
(Date:9/3/2008)... Company Focuses Operations, Updates Zingo Launch ...ation Strategy Conference Call To...Sept. 3 /- Anesiva,Inc. (N...ll restructure,operations to focus on commercial a...s transition to a specialty pharmaceutical pain ma...
Breaking Medicine Technology:CDC Misses Target With Flawed MMR/Autism Study 2Favourable Six Months Follow-Up Results From Intercell's Phase II Therapeutic Hepatitis C Program 2Favourable Six Months Follow-Up Results From Intercell's Phase II Therapeutic Hepatitis C Program 3Favourable Six Months Follow-Up Results From Intercell's Phase II Therapeutic Hepatitis C Program 4Panacea Pharmaceuticals Announces Issuance of a U.S. Patent Covering Anti-HAAH Antibodies 2Panacea Pharmaceuticals Announces Issuance of a U.S. Patent Covering Anti-HAAH Antibodies 3Panacea Pharmaceuticals Announces Issuance of a U.S. Patent Covering Anti-HAAH Antibodies 4Anesiva Accelerates Its Transition to Specialty Pharma Pain Management Company 2Anesiva Accelerates Its Transition to Specialty Pharma Pain Management Company 3Anesiva Accelerates Its Transition to Specialty Pharma Pain Management Company 4Anesiva Accelerates Its Transition to Specialty Pharma Pain Management Company 5ZONARE Names Marcotte Chief Financial Officer 4588 1ZONARE Names Marcotte Chief Financial Officer 4588 2New Survey Shows Majority of Employers Rank Smoking as One of Their Greatest Priority Health Issues But Only 2 Percent Provide Comprehensive Smoking 4584 1New Survey Shows Majority of Employers Rank Smoking as One of Their Greatest Priority Health Issues But Only 2 Percent Provide Comprehensive Smoking 4584 2New Survey Shows Majority of Employers Rank Smoking as One of Their Greatest Priority Health Issues But Only 2 Percent Provide Comprehensive Smoking 4584 3New Survey Shows Majority of Employers Rank Smoking as One of Their Greatest Priority Health Issues But Only 2 Percent Provide Comprehensive Smoking 4584 4New Survey Shows Majority of Employers Rank Smoking as One of Their Greatest Priority Health Issues But Only 2 Percent Provide Comprehensive Smoking 4584 5Leading Edge Research Underway in Fall Prevention for Seniors 1502 1Leading Edge Research Underway in Fall Prevention for Seniors 1502 2Leading Edge Research Underway in Fall Prevention for Seniors 1502 3Genzyme and Sunway to Collaborate on Gene Therapy Program in China 1498 1Genzyme and Sunway to Collaborate on Gene Therapy Program in China 1498 2Genzyme and Sunway to Collaborate on Gene Therapy Program in China 1498 3Genzyme and Sunway to Collaborate on Gene Therapy Program in China 1498 4
...age of More Than Two Hours Per Day, RESEARCH TRIAN...ing the once daily, investigational medication REQ...lease Tablets to,Parkinson,s patients, existing le..., time, allowing patients to continue,their daily ...,describes the return of Parkinson,s symptoms as a...
...ppresses Amyloid Plaque Formation, ANNAPOLIS, Md.,... a leading biodefense company specializing in the ...ermeasures against chemical,and biological terrori...nant butyrylcholinesterase (rBChE) research progra... Conference on,Alzheimer,s and Parkinson,s Disease...
Other Medicine Technology:Once Daily, Extended-Release Ropinirole Improves Parkinson's,Symptoms in Patients not Optimally Controlled With Levodopa 2Once Daily, Extended-Release Ropinirole Improves Parkinson's,Symptoms in Patients not Optimally Controlled With Levodopa 3Once Daily, Extended-Release Ropinirole Improves Parkinson's,Symptoms in Patients not Optimally Controlled With Levodopa 4Once Daily, Extended-Release Ropinirole Improves Parkinson's,Symptoms in Patients not Optimally Controlled With Levodopa 5PharmAthene's Recombinant Butyrylcholinesterase (rBChE) Program the,Subject of Promising New Alzheimer's Research 2PharmAthene's Recombinant Butyrylcholinesterase (rBChE) Program the,Subject of Promising New Alzheimer's Research 3PharmAthene's Recombinant Butyrylcholinesterase (rBChE) Program the,Subject of Promising New Alzheimer's Research 4PharmAthene's Recombinant Butyrylcholinesterase (rBChE) Program the,Subject of Promising New Alzheimer's Research 5PharmAthene's Recombinant Butyrylcholinesterase (rBChE) Program the,Subject of Promising New Alzheimer's Research 6